Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

WW Domain-Containing Oxidoreductase × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 5 Thoracic 3 Other solid neoplasm 3 Genitourinary 3 Other hematologic neoplasm 2 Lymphoid 2 Breast 2 Tumor-Agnostic 1 Head & Neck 1 Gastrointestinal 1

Conditions

Head and Neck Fibrosis 1

Interventions

Cisplatin 550 Radiotherapy 298 pembrolizumab 289 Cetuximab 244 Docetaxel 200 Radiotherapy, Intensity-Modulated 197 Fluorouracil 177 Carboplatin 174 Paclitaxel 148 Nivolumab 127 Gemcitabine 113 Radiation 82 Magnetic Resonance Spectroscopy 81 Drug Therapy 75 toripalimab 68 Capecitabine 67 Surveys and Questionnaires 64 Surgical Procedures, Operative 62 Biopsy 58 durvalumab 55 Blood Specimen Collection 48 Cyclophosphamide 43 Chemoradiotherapy 43 camrelizumab 41 Standard of Care 39 Specimen Handling 39 Erlotinib Hydrochloride 38 Bevacizumab 38 tislelizumab 37 Radiosurgery 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03723291 2026-03-03

PITSTOP

University College, London

Phase 1 Completed

Head and Neck Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡